万维提示：
1、投稿方式：在线投稿。
2、期刊网址：
http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journal
3、投稿网址：
https://www.dovepress.com/submit_step_1.php
4、期刊刊期：不定期出版。
2022年1月18日星期二
期刊信息【官网信息】
Clinical, Cosmetic and Investigational Dermatology
Aims and Scope
Clinical, Cosmetic and Investigational Dermatology is an international, peer-reviewed, open access journal that focuses on the latest clinical and experimental research in all aspects of skin disease and cosmetic interventions.
Meta-analyses will no longer be considered for publication.
Specific topics covered by the journal include:
Normal and pathological processes in skin development and aging, their modification and treatment
Basic research into histology of dermal structures
Clinical insights and potential treatment options
Patient satisfaction, preference, quality of life, compliance
Development of new management options to optimize outcomes for target conditions
The journal is characterized by the rapid reporting of clinical studies, reviews and original research in skin research and skin care.
Call For Papers
o see where Clinical, Cosmetic and Investigational Dermatology is indexed online view the Journal Metrics.
What is the advantage to you of publishing in Clinical, Cosmetic and Investigational Dermatology?
It is an open access journal which means that your paper is available to anyone in the world to download for free directly from the Dove website.
Although Clinical, Cosmetic and Investigational Dermatology receives a lot of papers, unlike many traditional journals, your paper will not be rejected due to lack of space. We are an electronic journal and there are no limits on the number or size of the papers we can publish.
The time from submission to a decision being made on a paper can, in many journals, take some months and this is very frustrating for authors. Clinical, Cosmetic and Investigational Dermatology has a quicker turnaround time than this. Generally peer review is complete within 3-4 weeks and the editor’s decision within 2-14 days of this. It is therefore very rare to have to wait more than 6 weeks for first editorial decision.
Many authors have found that our peer reviewer’s comments substantially add to their final papers.
To recover our editorial and production costs and continue to provide our content at no cost to readers we charge authors or their institution a publication processing fee.
PubMed Central
Clinical, Cosmetic and Investigational Dermatology is indexed on PubMed Central (title abbreviation: Clin Cosmet Investig Dermatol). All published papers in this journal are submitted to PubMed for indexing straight away.
Become a Favored Author and receive real benefits
If you haven't already joined the Dove Press Favored Author Program I would encourage you to do so. Why? To receive real benefits like fast-tracking and a personal co-ordinator for your paper, as well as a discount on the publication processing fee.
Click here to go through to the Favored Author signup page, you'll just need to supply the working title of your next paper and when you intend to submit by.
Yours sincerely
Dr Jeffrey M. Weinberg
Editor-in-Chief
Clinical, Cosmetic and Investigational Dermatology
Email: Editor-in-Chief
